A global shift in scientific and medical research is under way as countries hope to phase out experimentation on animals – but Australia risks being left behind.
The transition from using animals to alternatives based on human cells, tissue and data is driving multibillion-dollar growth in new technologies and methods. However, industry leaders and insiders warn Australia will miss those opportunities due to a lack of funding, opaque record keeping and national inconsistencies.
